Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Should we avoid using ketoconazole in patients with severe Cushing’s syndrome and increased levels of liver enzymes?

Ollivier M, Haissaguerre M, Ferriere F, Tabarin A.

Eur J Endocrinol. 2018 Oct 12;179(5):L1-L2. doi: 10.1530/EJE-18-0694.

PMID:
30320504
2.

Hair cortisol analysis: An update on methodological considerations and clinical applications.

Greff MJE, Levine JM, Abuzgaia AM, Elzagallaai AA, Rieder MJ, van Uum SHM.

Clin Biochem. 2019 Jan;63:1-9. doi: 10.1016/j.clinbiochem.2018.09.010. Epub 2018 Sep 24. Review.

PMID:
30261181
3.

Active cushing syndrome patients have increased ectopic fat deposition and bone marrow fat content compared to cured patients and healthy subjects: a pilot 1H-MRS study.

Maurice F, Dutour A, Vincentelli C, Abdesselam I, Bernard M, Dufour H, Le Fur Y, Graillon T, Kober F, Cristofari P, Jouve E, Pini L, Fernandez R, Chagnaud C, Brue T, Castinetti F, Gaborit B.

Eur J Endocrinol. 2018 Oct 12;179(5):307-317. doi: 10.1530/EJE-18-0318.

PMID:
30108093
4.

New and emerging drug therapies for Cushing's disease.

Störmann S, Schopohl J.

Expert Opin Pharmacother. 2018 Aug;19(11):1187-1200. doi: 10.1080/14656566.2018.1504021. Epub 2018 Jul 26. Review.

PMID:
30048162
5.

Effectiveness of unilateral laparoscopic adrenalectomy in ACTH-independent hypercortisolaemia and subclinical Cushing's syndrome - a retrospective study on a large cohort.

Pogorzelski R, Toutounchi S, Ambroziak U, Krajewska E, Wołoszko T, Szostek M, Jakuczun W, Celejewski K, Legocka M, Kwasiborski P, Gałązka Z, Biskup E.

Endokrynol Pol. 2018;69(4):411-415. doi: 10.5603/EP.a2018.0039. Epub 2018 Jun 28.

6.

TSH ratio as a novel diagnostic method for Cushing's syndrome.

Tamada D, Kitamura T, Takahara M, Tanaka T, Takeda M, Otsuki M, Shimomura I.

Endocr J. 2018 Aug 27;65(8):841-848. doi: 10.1507/endocrj.EJ18-0101. Epub 2018 Jun 19.

7.

Metabolic Syndrome in Cushing's Syndrome Patients.

Ferraù F, Korbonits M.

Front Horm Res. 2018;49:85-103. doi: 10.1159/000486002. Epub 2018 Apr 5. Review.

PMID:
29894989
8.

Surviving ectopic Cushing's syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing's disease during long-term follow-up.

Osswald A, Deutschbein T, Berr CM, Plomer E, Mickisch A, Ritzel K, Schopohl J, Beuschlein F, Fassnacht M, Hahner S, Reincke M.

Eur J Endocrinol. 2018 Aug;179(2):109-116. doi: 10.1530/EJE-18-0212. Epub 2018 Jun 6.

PMID:
29875286
9.

Effectiveness of medical treatment for Cushing's syndrome: a systematic review and meta-analysis.

Broersen LHA, Jha M, Biermasz NR, Pereira AM, Dekkers OM.

Pituitary. 2018 Dec;21(6):631-641. doi: 10.1007/s11102-018-0897-z. Review.

10.

Genomic insights into Cushing syndrome.

Assié G.

Ann Endocrinol (Paris). 2018 Jun;79(3):119-122. doi: 10.1016/j.ando.2018.03.011. Epub 2018 May 4. Review.

PMID:
29735160
11.

Increased Urinary Extracellular Vesicle Sodium Transporters in Cushing Syndrome With Hypertension.

Salih M, Bovée DM, van der Lubbe N, Danser AHJ, Zietse R, Feelders RA, Hoorn EJ.

J Clin Endocrinol Metab. 2018 Jul 1;103(7):2583-2591. doi: 10.1210/jc.2018-00065.

PMID:
29726949
12.

Low-Dose and Standard Overnight and Low Dose-Two Day Dexamethasone Suppression Tests in Patients with Mild and/or Episodic Hypercortisolism.

Mojtahedzadeh M, Shaesteh N, Haykani M, Tran JLA, Mangubat M, Shahinian HK, Nachnani R, Zopey M, Saidian J, Thomas A, Lee ML, McCutcheon IE, Friedman TC.

Horm Metab Res. 2018 Jun;50(6):453-461. doi: 10.1055/a-0603-3868. Epub 2018 May 2.

PMID:
29719879
13.

The difficulties of pseudo-Cushing's syndrome (or "non-neoplastic hypercortisolism").

Chabre O.

Ann Endocrinol (Paris). 2018 Jun;79(3):138-145. doi: 10.1016/j.ando.2018.04.017. Epub 2018 Apr 30. Review.

PMID:
29716734
14.

Clinical Investigation of Adrenal Incidentalomas in Japanese Patients of the Fukuoka Region with Updated Diagnostic Criteria for Sub-clinical Cushing's Syndrome.

Abe I, Sugimoto K, Miyajima T, Ide T, Minezaki M, Takeshita K, Takahara S, Nakagawa M, Fujimura Y, Kudo T, Miyajima S, Taira H, Ohe K, Ishii T, Yanase T, Kobayashi K.

Intern Med. 2018 Sep 1;57(17):2467-2472. doi: 10.2169/internalmedicine.0550-17. Epub 2018 Apr 27.

15.

Connshing syndrome - myth or reality?

Beuschlein F.

Ann Endocrinol (Paris). 2018 Jun;79(3):123-124. doi: 10.1016/j.ando.2018.03.017. Epub 2018 Apr 16. No abstract available.

PMID:
29673695
16.

MECHANISMS IN ENDOCRINOLOGY: A sense of time of the glucocorticoid circadian clock: from the ontogeny to the diagnosis of Cushing's syndrome.

Moreira AC, Antonini SR, de Castro M.

Eur J Endocrinol. 2018 Jul;179(1):R1-R18. doi: 10.1530/EJE-18-0102. Epub 2018 Apr 16. Review.

PMID:
29661784
17.

Do the diagnostic criteria for subclinical hypercortisolism exist?

Tabarin A.

Ann Endocrinol (Paris). 2018 Jun;79(3):146-148. doi: 10.1016/j.ando.2018.03.013. Epub 2018 Apr 13. Review.

PMID:
29661471
18.

An update on Cushing syndrome in pediatrics.

Stratakis CA.

Ann Endocrinol (Paris). 2018 Jun;79(3):125-131. doi: 10.1016/j.ando.2018.03.010. Epub 2018 Apr 9. Review.

PMID:
29650225
19.

Dynamic changes of central thyroid functions in the management of Cushing's syndrome.

Dogansen SC, Yalin GY, Canbaz B, Tanrikulu S, Yarman S.

Arch Endocrinol Metab. 2018 Apr 5;62(2):164-171. doi: 10.20945/2359-3997000000019. Print 2018 Mar-Apr.

20.

Cardiovascular mortality in patients with subclinical Cushing.

Morelli V, Arosio M, Chiodini I.

Ann Endocrinol (Paris). 2018 Jun;79(3):149-152. doi: 10.1016/j.ando.2018.03.005. Epub 2018 Mar 30. Review.

PMID:
29606280

Supplemental Content

Loading ...
Support Center